(Q37126896)

18 August 2017

1 reference

title

Blocking IL-1: interleukin 1 receptor antagonist in vivo and in vitro (English)

1 reference

18 August 2017

0 references

1 reference

https://api.crossref.org/works/10.1016/0167-5699(91)90142-G

6 December 2022

1

Dinarello CA

1 reference

18 August 2017

Thompson RC

2

1 reference

18 August 2017

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1838480

6 December 2022

publication date

1 November 1991

1 reference

full work available at URL

18 August 2017

https://api.elsevier.com/content/article/PII:016756999190142G?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0167-5699(91)90142-G

https://api.elsevier.com/content/article/PII:016756999190142G?httpAccept=text/plain

6 December 2022

1 reference

https://api.crossref.org/works/10.1016/0167-5699(91)90142-G

6 December 2022

1 reference

18 August 2017

12

1 reference

18 August 2017

404-410

1 reference

18 August 2017

11

1 reference

Preliminary report: effects of interleukin-1 on platelet counts

18 August 2017

1

1 reference

https://api.crossref.org/works/10.1016/0167-5699(91)90142-G

Cloning and expression of murine interleukin-1 cDNA in Escherichia coli

6 December 2022

4

1 reference

https://api.crossref.org/works/10.1016/0167-5699(91)90142-G

Interleukin 1: the first interleukin.

6 December 2022

7

1 reference

https://api.crossref.org/works/10.1016/0167-5699(91)90142-G

Native interleukin 1 inhibitors

6 December 2022

8

1 reference

https://api.crossref.org/works/10.1016/0167-5699(91)90142-G

Interleukin 1 inhibitory activity secreted by a human myelomonocytic cell line (M20)

6 December 2022

10

1 reference

https://api.crossref.org/works/10.1016/0167-5699(91)90142-G

Autoantibodies to cytokines--friends or foes?

6 December 2022

11

1 reference

https://api.crossref.org/works/10.1016/0167-5699(91)90142-G

Prostaglandin E2 and collagenase production by fibroblasts and synovial cells is regulated by urine-derived human interleukin 1 and inhibitor(s)

6 December 2022

13

1 reference

https://api.crossref.org/works/10.1016/0167-5699(91)90142-G

Interleukin-1 receptor antagonist activity of a human interleukin-1 inhibitor

6 December 2022

17

1 reference

https://api.crossref.org/works/10.1016/0167-5699(91)90142-G

Primary structure and functional expression from complementary DNA of a human interleukin-1 receptor antagonist

6 December 2022

18

1 reference

https://api.crossref.org/works/10.1016/0167-5699(91)90142-G

Purification, cloning, expression and biological characterization of an interleukin-1 receptor antagonist protein

6 December 2022

20

1 reference

https://api.crossref.org/works/10.1016/0167-5699(91)90142-G

6 December 2022

25

9

599

Young

1990

1 reference

https://api.crossref.org/works/10.1016/0167-5699(91)90142-G

cDNA expression cloning of the IL-1 receptor, a member of the immunoglobulin superfamily

6 December 2022

26

1 reference

https://api.crossref.org/works/10.1016/0167-5699(91)90142-G

The interleukin-1 receptor in Raji human B-lymphoma cells. Molecular characterization and evidence for receptor-mediated activation of gene expression

6 December 2022

27

1 reference

https://api.crossref.org/works/10.1016/0167-5699(91)90142-G

Differential binding of IL-1 alpha and IL-1 beta to receptors on B and T cells

6 December 2022

28

1 reference

https://api.crossref.org/works/10.1016/0167-5699(91)90142-G

Inhibition of interleukin 1 (IL-1) binding and bioactivity in vitro and modulation of acute inflammation in vivo by IL-1 receptor antagonist and anti-IL-1 receptor monoclonal antibody

6 December 2022

34

1 reference

https://api.crossref.org/works/10.1016/0167-5699(91)90142-G

Biological properties of recombinant human monocyte-derived interleukin 1 receptor antagonist

6 December 2022

35

1 reference

https://api.crossref.org/works/10.1016/0167-5699(91)90142-G

Interleukin-1 receptor antagonist reduces mortality from endotoxin shock

6 December 2022

37

1 reference

https://api.crossref.org/works/10.1016/0167-5699(91)90142-G

A specific receptor antagonist for interleukin 1 prevents Escherichia coli ‐induced shock in rabbits

6 December 2022

38

1 reference

https://api.crossref.org/works/10.1016/0167-5699(91)90142-G

A recombinant human receptor antagonist to interleukin 1 improves survival after lethal endotoxemia in mice

6 December 2022

40

1 reference

https://api.crossref.org/works/10.1016/0167-5699(91)90142-G

Staphylococcus epidermidis induces complement activation, tumor necrosis factor and interleukin-1, a shock-like state and tissue injury in rabbits without endotoxemia. Comparison to Escherichia coli

6 December 2022

43

1 reference

https://api.crossref.org/works/10.1016/0167-5699(91)90142-G

Interleukin 1 (IL-1) gene expression, synthesis, and effect of specific IL-1 receptor blockade in rabbit immune complex colitis

6 December 2022

44

1 reference

https://api.crossref.org/works/10.1016/0167-5699(91)90142-G

Interleukin 1 inhibits contraction of vascular smooth muscle

6 December 2022

45

1 reference

https://api.crossref.org/works/10.1016/0167-5699(91)90142-G

Interleukin 1-dependent paracrine granulopoiesis in chronic granulocytic leukemia of the juvenile type

6 December 2022

47

1 reference

https://api.crossref.org/works/10.1016/0167-5699(91)90142-G

Affinity-purified human interleukin I is cytotoxic to isolated islets of Langerhans

6 December 2022

50

1 reference

https://api.crossref.org/works/10.1016/0167-5699(91)90142-G

Cytotoxicity of human pI 7 interleukin-1 for pancreatic islets of Langerhans

6 December 2022

51

1 reference

https://api.crossref.org/works/10.1016/0167-5699(91)90142-G

A natural interleukin 1 (IL-1) inhibitor counteracts the inhibitory effect of IL-1 on insulin production in cultured rat pancreatic islets

6 December 2022

52

1 reference

https://api.crossref.org/works/10.1016/0167-5699(91)90142-G

An overview on interleukin-1 as a therapeutic agent

6 December 2022

59

1 reference

https://api.crossref.org/works/10.1016/0167-5699(91)90142-G

Specific interleukin-1 inhibitor in serum and urine of children with systemic juvenile chronic arthritis

6 December 2022

65

1 reference

https://api.crossref.org/works/10.1016/0167-5699(91)90142-G

Extension of the life-span of human endothelial cells by an interleukin-1 alpha antisense oligomer

6 December 2022

70

1 reference

https://api.crossref.org/works/10.1016/0167-5699(91)90142-G

American Journal of Physiology

6 December 2022

73

260

R453

Opp

1991

1 reference

https://api.crossref.org/works/10.1016/0167-5699(91)90142-G

Tumor necrosis factor alpha/cachectin and interleukin 1 beta initiate meningeal inflammation

6 December 2022

74

1 reference

https://api.crossref.org/works/10.1016/0167-5699(91)90142-G

Roles of interleukin-1 and tumor necrosis factor in lipopolysaccharide-induced hypoglycemia

6 December 2022

75

1 reference

https://api.crossref.org/works/10.1016/0167-5699(91)90142-G

6 December 2022

Molecular Pharmacology

76

39

105

Miller

1991

1 reference

https://api.crossref.org/works/10.1016/0167-5699(91)90142-G

Biologic effects of an interleukin-1 receptor antagonist protein on interleukin-1–stimulated cartilage erosion and chondrocyte responsiveness

6 December 2022

77

1 reference

https://api.crossref.org/works/10.1016/0167-5699(91)90142-G

An interleukin-1 receptor antagonist blocks lipopolysaccharide-induced colony-stimulating factor production and early endotoxin tolerance.

6 December 2022

80

1 reference

https://api.crossref.org/works/10.1016/0167-5699(91)90142-G

6 December 2022

83

9

612

Numerof

1990

1 reference

https://api.crossref.org/works/10.1016/0167-5699(91)90142-G

6 December 2022

Identifiers

1 reference

18 August 2017

1 reference